Tanner Pharma Group Announces New EVP of Technical Operations

CHARLOTTE, N.C.–(BUSINESS WIRE)–Tanner Pharma Group (“Tanner”), a global pharma-solutions provider, today announced the hiring of Lee Holmes as Executive Vice President of Technical Operations.

Having worked in the healthcare industry for over 25 years across a wide range of global leadership roles, Lee brings with him a wealth of industry knowledge and experience, offering particularly significant expertise in the development and supply of specialty pharmaceuticals and specialized, niche medicine. Prior to joining Tanner, Lee held various commercial and operational roles within biotechnology and pharmaceutical companies and service providers (notably Clinigen and WEP Clinical) and was most recently managing his own consulting company.

“Lee’s strong leadership skills and expansive background in healthcare and pharma make him a great asset to our Tanner team,” said Banks Bourne, Founder and Chairman of Tanner Pharma Group and CEO of Bourne Partners, the parent company and Tanner Pharma Group. “His focus on and passion for the patient access space couldn’t be better aligned with our mission.”

“We are pleased to welcome Lee to our Tanner family and look forward to the expertise he will bring as we move forward into our next stage of growth,” added Steve Scalia, President of Tanner Pharma Group.

As EVP of Technical Operations, Lee will help drive Tanner’s global expansion by leading and further developing the company’s operational capabilities across the supply chain, logistics, quality assurance, and regulatory segments.

About Tanner Pharma Group:

For over 19 years, Tanner Pharma Group has partnered with companies to provide turn-key solutions to increase access to medicines and other medical technology around the world. By partnering with Tanner Pharma Group, companies are able to focus on their primary markets while ensuring that patients and clinicians in international markets can receive their products through a strictly controlled channel. Tanner Pharma Group is headquartered in the United States with offices in the United Kingdom, Switzerland, Ireland and Brazil. Tanner Pharma Group has a global reach and provides international commercialization and patient access through licensing, managed access programs, global access programs and clinical trial services. For more information, please visit www.tannerpharma.com.

Tanner Pharma Group Media Contact:
Lindsey Stevens

Tanner Pharma Group uses cookies on its website. By continuing to access this website you are agreeing to Tanner Pharma Group’s Data Privacy Policy. For more information, click here.